Cargando…
Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurodegenerative disease. Levodopa in combination with amantadine has a demonstrated efficacy in motility impairment. An extensive investigation of some enzymes described to be upregulated or downregulated in PD was made – adenylate kinase (AK), adenine pho...
Autor principal: | Ionescu, Mihaela Ileana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Association of Physical Chemists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915579/ https://www.ncbi.nlm.nih.gov/pubmed/35300368 http://dx.doi.org/10.5599/admet.854 |
Ejemplares similares
-
Investigation of the Long-Term Effects of Amantadine Use in Parkinson’s Disease
por: Park, Sangmin, et al.
Publicado: (2023) -
Amantadine, COVID-19 and Parkinsonism
por: Wiwanitkit, Viroj
Publicado: (2020) -
Molecular docking studies of salubrinal and its analogs as inhibitors of the GADD34:PP1 enzyme
por: Zadorozhnii, Pavlo V., et al.
Publicado: (2019) -
Response to: Amantadine, COVID-19 and Parkinsonism
por: Aranda-Abreu, Gonzalo Emiliano
Publicado: (2020) -
Amantadine-Induced Patulous Eustachian Tubes in Parkinson's Disease
por: Boyd, J. T., et al.
Publicado: (2013)